BACKGROUND: We hypothesize that left-sided low-level vagus nerve stimulation (LL-VNS) can suppress sympathetic outflow and reduce atrial tachyarrhythmias in ambulatory dogs. METHODS AND RESULTS: We implanted a neurostimulator in 12 dogs to stimulate the left cervical vagus nerve and a radiotransmitter for continuous recording of left stellate ganglion nerve activity, vagal nerve activities, and ECGs. Group 1 dogs (N=6) underwent 1 week of continuous LL-VNS. Group 2 dogs (N=6) underwent intermittent rapid atrial pacing followed by active or sham LL-VNS on alternate weeks. Integrated stellate ganglion nerve activity was significantly reduced during LL-VNS (7.8 mV/s; 95% confidence interval [CI] 6.94 to 8.66 versus 9.4 mV/s [95% CI, 8.5 to 10.3] at baseline; P=0.033) in group 1. The reduction was most apparent at 8 am, along with a significantly reduced heart rate (P=0.008). Left-sided low-level vagus nerve stimulation did not change vagal nerve activity. The density of tyrosine hydroxylase-positive nerves in the left stellate ganglion 1 week after cessation of LL-VNS were 99 684 μm(2)/mm(2) (95% CI, 28 850 to 170 517) in LL-VNS dogs and 186 561 μm(2)/mm(2) (95% CI, 154 956 to 218 166; P=0.008) in normal dogs. In group 2, the frequencies of paroxysmal atrial fibrillation and tachycardia during active LL-VNS were 1.4/d (95% CI, 0.5 to 5.1) and 8.0/d (95% CI, 5.3 to 12.0), respectively, significantly lower than during sham stimulation (9.2/d [95% CI, 5.3 to 13.1]; P=0.001 and 22.0/d [95% CI, 19.1 to 25.5], P<0.001, respectively). CONCLUSIONS: Left-sided low-level vagus nerve stimulation suppresses stellate ganglion nerve activities and reduces the incidences of paroxysmal atrial tachyarrhythmias in ambulatory dogs. Significant neural remodeling of the left stellate ganglion is evident 1 week after cessation of continuous LL-VNS.
BACKGROUND: We hypothesize that left-sided low-level vagus nerve stimulation (LL-VNS) can suppress sympathetic outflow and reduce atrial tachyarrhythmias in ambulatory dogs. METHODS AND RESULTS: We implanted a neurostimulator in 12 dogs to stimulate the left cervical vagus nerve and a radiotransmitter for continuous recording of left stellate ganglion nerve activity, vagal nerve activities, and ECGs. Group 1 dogs (N=6) underwent 1 week of continuous LL-VNS. Group 2 dogs (N=6) underwent intermittent rapid atrial pacing followed by active or sham LL-VNS on alternate weeks. Integrated stellate ganglion nerve activity was significantly reduced during LL-VNS (7.8 mV/s; 95% confidence interval [CI] 6.94 to 8.66 versus 9.4 mV/s [95% CI, 8.5 to 10.3] at baseline; P=0.033) in group 1. The reduction was most apparent at 8 am, along with a significantly reduced heart rate (P=0.008). Left-sided low-level vagus nerve stimulation did not change vagal nerve activity. The density of tyrosine hydroxylase-positive nerves in the left stellate ganglion 1 week after cessation of LL-VNS were 99 684 μm(2)/mm(2) (95% CI, 28 850 to 170 517) in LL-VNS dogs and 186 561 μm(2)/mm(2) (95% CI, 154 956 to 218 166; P=0.008) in normal dogs. In group 2, the frequencies of paroxysmal atrial fibrillation and tachycardia during active LL-VNS were 1.4/d (95% CI, 0.5 to 5.1) and 8.0/d (95% CI, 5.3 to 12.0), respectively, significantly lower than during sham stimulation (9.2/d [95% CI, 5.3 to 13.1]; P=0.001 and 22.0/d [95% CI, 19.1 to 25.5], P<0.001, respectively). CONCLUSIONS: Left-sided low-level vagus nerve stimulation suppresses stellate ganglion nerve activities and reduces the incidences of paroxysmal atrial tachyarrhythmias in ambulatory dogs. Significant neural remodeling of the left stellate ganglion is evident 1 week after cessation of continuous LL-VNS.
Authors: John C Lopshire; Xiaohong Zhou; Cristian Dusa; Takeshi Ueyama; Joshua Rosenberger; Nicole Courtney; Michael Ujhelyi; Thomas Mullen; Mithilesh Das; Douglas P Zipes Journal: Circulation Date: 2009-07-13 Impact factor: 29.690
Authors: Arthur A M Wilde; Zahurul A Bhuiyan; Lia Crotti; Mario Facchini; Gaetano M De Ferrari; Thomas Paul; Chiara Ferrandi; Dave R Koolbergen; Attilio Odero; Peter J Schwartz Journal: N Engl J Med Date: 2008-05-08 Impact factor: 91.245
Authors: Youhua Zhang; Zoran B Popovic; Steve Bibevski; Itaf Fakhry; Domenic A Sica; David R Van Wagoner; Todor N Mazgalev Journal: Circ Heart Fail Date: 2009-09-22 Impact factor: 8.790
Authors: David Hamon; Pradeep S Rajendran; Ray W Chui; Olujimi A Ajijola; Tadanobu Irie; Ramin Talebi; Siamak Salavatian; Marmar Vaseghi; Jason S Bradfield; J Andrew Armour; Jeffrey L Ardell; Kalyanam Shivkumar Journal: Circ Arrhythm Electrophysiol Date: 2017-04
Authors: Olujimi A Ajijola; Daigo Yagishita; Naveen K Reddy; Kentaro Yamakawa; Marmar Vaseghi; Anthony M Downs; Donald B Hoover; Jeffrey L Ardell; Kalyanam Shivkumar Journal: Heart Rhythm Date: 2015-01-30 Impact factor: 6.343
Authors: Evon S Ereifej; Courtney E Shell; Jonathon S Schofield; Hamid Charkhkar; Ivana Cuberovic; Alan D Dorval; Emily L Graczyk; Takashi D Y Kozai; Kevin J Otto; Dustin J Tyler; Cristin G Welle; Alik S Widge; José Zariffa; Chet T Moritz; Dennis J Bourbeau; Paul D Marasco Journal: J Neural Eng Date: 2019-11-12 Impact factor: 5.379
Authors: Yuan Yuan; Ye Zhao; Johnson Wong; Wei-Chung Tsai; Zhaolei Jiang; Ryan A Kabir; Seongwook Han; Changyu Shen; Michael C Fishbein; Lan S Chen; Zhenhui Chen; Thomas H Everett; Peng-Sheng Chen Journal: Heart Rhythm Date: 2020-02-14 Impact factor: 6.343
Authors: Eric A Robinson; Kyoung-Suk Rhee; Anisiia Doytchinova; Mohineesh Kumar; Richard Shelton; Zhaolei Jiang; Nicholas J Kamp; David Adams; David Wagner; Changyu Shen; Lan S Chen; Thomas H Everett; Michael C Fishbein; Shien-Fong Lin; Peng-Sheng Chen Journal: J Cardiovasc Electrophysiol Date: 2014-09-04